Imspc Biotech
Latest round
- Angel
Last raised
- May 2024
Total raised
- Undisclosed
Investors
- 1
About Imspc Biotech
Established in 2023 and based in Suzhou, China, Imspc Biotech is a healthcare IT company that focuses on providing medical solutions for hyperuricemia. The CEO of this company, Xiang Leng, has worked for Johnson & Johnson and Ping An and has nearly two decades of healthcare experience. It released a gout risk assessment test based on Liquid Chromatograph Mass Spectrometer (LC-MS) technology on April 20, 2024., Ltd and Biotree. The company’s main business is the provision of precise diagnostic services and innovative treatment solutions for hyperuricemia and gout. The company’s self-developed products include mass spectrometry testing for small molecule metabolites and AI algorithms for gout risk assessment. Its products and services are used in the field of medical diagnostics, specifically for the early detection and treatment of hyperuricemia and gout. It also provides gout-targeted drugs, health management service system, health insurance, customized nutritional products, and medical assistance. Imspc Biotech generates revenue by providing comprehensive diagnostic services.
Who invested in Imspc Biotech
1 investor across 1 round
See all investors in Imspc Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
May 28, 2024
Amount
Undisclosed
Investors
Questions about Imspc Biotech
Who invested in Imspc Biotech?
Imspc Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Imspc Biotech raised?
Imspc Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Imspc Biotech last raise money?
Imspc Biotech's most recent round on record is a Angel, in May 2024.
What does Imspc Biotech do?
Established in 2023 and based in Suzhou, China, Imspc Biotech is a healthcare IT company that focuses on providing medical solutions for hyperuricemia.
Where is Imspc Biotech headquartered?
Imspc Biotech is headquartered in Suzhou, China.
Which VCs invest in companies like Imspc Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare it companies at Imspc Biotech's stage. Their profiles are linked below.
VCs backing healthcare it startups at Angel
Raising like Imspc Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.